BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/16/2019 12:41:28 AM | Browse: 858 | Download: 1102
 |
Received |
|
2019-03-18 05:34 |
|
Peer-Review Started |
|
2019-03-20 06:10 |
|
To Make the First Decision |
|
2019-06-05 06:35 |
|
Return for Revision |
|
2019-06-06 03:46 |
|
Revised |
|
2019-06-22 07:34 |
|
Second Decision |
|
2019-07-01 00:22 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-07-17 16:49 |
|
Articles in Press |
|
2019-07-17 16:49 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-08-15 05:57 |
|
Publish the Manuscript Online |
|
2019-08-16 00:41 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019 Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng and Sung-Hsin Kuo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Ministry of Science and Technology, Taiwan |
MOST 107-2314-B-002-217-MY3 |
| National Taiwan University Hospital, Taiwan |
NTUH 108-S4143 |
|
| Corresponding Author |
Sung-Hsin Kuo, MD, PhD, Professor, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 100, Taiwan. shkuo101@ntu.edu.tw |
| Key Words |
Hepatocellular carcinoma; Proton beam therapy; Carbon ion radiotherapy; Local control; Toxicity; Overall survival |
| Core Tip |
Charged particle therapy (CPT) for hepatocelluar carcinoma (HCC), including proton beam therapy and carbon ion radiotherapy, offers physics-related advantages and results in better local control rates and lesser adverse effects. For peripherally large-sized HCC tumors, the hypo-fractionation regimen of CPT provides the benefit of increasing local control rates through overcoming radio-resistance, whereas conventional CPT is preferred for treating central tumors of HCC in terms of avoiding late toxicities of the biliary tract. Prospective data that will add to the accumulated evidence on the dosimetric constraints of hypofractionated CPT for the treatment of HCC are needed. |
| Publish Date |
2019-08-16 00:41 |
| Citation |
Hsu CY, Wang CW, Cheng AL, Kuo SH. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness. World J Gastrointest Oncol 2019; 11(8): 579-588 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i8/579.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i8.579 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
